UpdateBot: robot: Update article (please report if you notice any mistake or error in this edit)

2021-12-08T14:09:09Z

robot: Update article (please report if you notice any mistake or error in this edit)

← Older revision		Revision as of 19:39, 8 December 2021
Line 39:		Line 39:
	==History ==		==History ==

	Strides was founded in 1990 by Arun Kumar as “Strides Pharmaceuticals Private Limited”. Over the years, it has grown through numerous strategic moves to attain its position of today.		Strides was founded in 1990 by Arun Kumar as “Strides Pharmaceuticals Private Limited”.<ref>{{cite web\|title=Arun Kumar aims to reinvent Strides Arcolab with eye on new opportunities\|url=https://www.businesstoday.in/magazine/cover-story/story/best-indian-ceos-2014-arun-kumar-strides-arcolab-pharma-139610-2014-12-11\|date=21 December 2014\|publisher=Business Today}}</ref> Over the years, it has grown through numerous strategic moves to attain its position of today.

	;Some of the key milestones and phases for Strides areː		;Some of the key milestones and phases for Strides areː
Line 78:		Line 78:

	===UK===		===UK===
	Strides operates in the UK through its step down wholly owned subsidiary Strides Pharma UK Ltd, who have been reliably supplying high-quality generics to Tier 1 & Tier 2 wholesalers in the retail sector as well as the [[~~NHS~~]] through [[Commercial Medicines Unit]] tenders.		Strides operates in the UK through its step down wholly owned subsidiary Strides Pharma UK Ltd, who have been reliably supplying high-quality generics to Tier 1 & Tier 2 wholesalers in the retail sector as well as the [[National Health Service]] through [[Commercial Medicines Unit]] tenders.

	===Germany, Austria and Switzerland (DACH region)===		===Germany, Austria and Switzerland (DACH region)===

imported>HHHHHYYYY: #suggestededit-add 1.0

2021-08-24T16:31:09Z

#suggestededit-add 1.0

New page

{{Short description|Pharmaceutical company headquartered in India}}{{Multiple issues|
{{COI|date=June 2019}}
{{advert|date=June 2019}}
{{primary sources|date=October 2014}}
}}
{{Use dmy dates|date=August 2018}}
{{Use Indian English|date=August 2018}}
{{Infobox company
| name = Strides Pharma Science Limited
| former_name = Strides Shasun Limited
| logo = Strideslogofinalsmall.svg
| logo_size = 180px
| image = StridesHQStar1.svg
| image_size = 300px
| image_caption = Strides Headquarters in Bengaluru, India
| type = MNC (several JVs, and subsidiaries)
| traded_as = {{ubl|{{NSE|STAR}}|{{BSE|532531}}}}
| foundation = 1990
| location = Strides House, [[Bilekahalli]], [[Bannerghatta Road]], [[Bangalore]], [[India]]|
| founder = Arun Kumar
| key_people = * Arun Kumar, Founder and Chairman of the Board
* Dr. R. Ananthanarayanan, CEO & Managing Director
* Badree Komandur, Executive Director & Group CFO
* Christoph Funke - Chief Operations Officer
| industry = [[Pharmaceutical]]
| products = General Tablets, Hard Gelatin Capsules, Soft Gelatin Capsules, Sachets, Semi Solids, Ointments, Creams
| revenue = {{profit}} {{INRconvert|2805|c}} (FY 2020)<ref name="FY2020">{{cite web |title=STATEMENT OF CONSOLIDATED AUDITED RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2020 |url=https://www.strides.com/pdf/financial%20results/annual_results/fy_2019-20/consolidated.pdf |publisher=strides.com |access-date=27 May 2021}}</ref>
| operating_income = {{profit}} {{INRconvert|239|c}} (FY 2020)<ref name="FY2020"/>
| net_income = {{profit}} {{INRconvert|54|c}} (FY 2020)<ref name="FY2020"/>
| num_employees = 3500+
| parent =
| subsid =
| homepage = {{url|www.strides.com}}
| footnotes =
}}

'''Strides Pharma Science Limited''', incorporated in 1990, is a [[pharmaceutical company]] headquartered in [[Bangalore]], [[India]]. The company is listed on the [[Bombay Stock Exchange]] and [[National Stock Exchange of India|National Stock Exchange]] of India Limited. Strides is engaged in the [[Drug development|development]], [[manufacture]], and [[marketing]] of pharmaceutical products for regulated and [[emerging markets]]. It has seven manufacturing facilities including four [[US Food and Drug Administration]] approved facilities. Strides also has in-house [[R&D]] [[infrastructure]] in Bengaluru, India.

==History ==

Strides was founded in 1990 by Arun Kumar as “Strides Pharmaceuticals Private Limited”. Over the years, it has grown through numerous strategic moves to attain its position of today.

;Some of the key milestones and phases for Strides areː
: 1990-94 - Incorporation and Initial Phase
:* Initial foray as an emerging market FDF company with third party manufacturing
: 1994-03 - Foray into Specialised manufacturing
:* Commenced manufacturing of sterile’s, soft-gel capsules, ARVs and anti-TB drugs
: 2004-08 - Front-end acquisitions and R&D pipeline
:* Acquisition of front-end platforms in SE Asia, Australia and India
: 2008-12 - Regulated markets focus
:* Partnerships with global pharmaceutical companies for regulated markets
: 2012-13 - Value creation in Strides 1.0
::: - Sale of Branded generics business in Australia (Ascent)
::::* Sale to Watson for A$375 million in 2012
::: -Sale of Specialty injectables(Operated as Agila)
::::* Sale to Mylan for enterprise value of up to US$1.75 billion in 2013
::::* Distributed dividends @ INR 605/share in FY14 and FY15; Total pay-out of US$655 million
: 2014- Current - Strides 2.0 with B2C Focus

==Business segments==
===Regulated markets===
* Front-end presence across the [[US]] , Europe, Canada and South Africa.
* Five facilities [Four [[USFDA]] approved] in [[India]], [[Europe]] and [[Singapore]].

===Emerging markets===
* Front-end focused markets of [[Africa]], [[Southeast Asia]] with a portfolio of branded generics
* Two manufacturing facilities dedicated for emerging market operations – One facility at [[Universal Corporation]], [[Kenya]] and one manufacturing facility in [[Bengaluru]], India
* Catering to donor-funded programmes using the local facility in [[Africa]].

==Key markets of operations==
===North America===
Strides Pharma Inc. is front-end company for Strides's operations in the US.

Strides re-entered the US market in 2015 post the divestment of its Specialty [[injectables]] franchisee- Agila to [[Mylan]] Inc. Its focus is mainly on niche, low volume, low competition, high technology barrier products built around Modified Releases, soft-gel capsules (SGCs), [[topicals]] and liquids. In the Consumer Healthcare space, Strides operate both in Brands as well as Private Labels and its key brands include JointFlex, Vanquish, Pediacare and Fergon. At the end of July 2018, Strides had a portfolio of 100+ filed ANDAs [[Abbreviated New Drug Application|ANDAs]] with 65+ product approvals.

===Africa===
Strides business activities in this continent are driven by the philosophy of “In [[Africa]] for [[Africa]]” which it bolstered with the acquisition of a [[WHO]]-approved facility under Universal Corporations in [[Kenya]]. Strides has a significant sales footprint in 40+ [[African countries]] with a robust medical field force in [[Africa]] that helps extend reach to 30,000 doctors.

===UK===
Strides operates in the UK through its step down wholly owned subsidiary Strides Pharma UK Ltd, who have been reliably supplying high-quality generics to Tier 1 & Tier 2 wholesalers in the retail sector as well as the [[NHS]] through [[Commercial Medicines Unit]] tenders.

===Germany, Austria and Switzerland (DACH region)===
Strides Pharma Global Pte Ltd has acquired a majority stake in Fairmed Healthcare AG, a Switzerland based company with a portfolio of high‐quality generic products encompassing prescription and over‐the‐counter drugs across several therapeutic segments. Fairmed Healthcare has built a strong franchise of supplying high‐quality Rx and OTC products in key European markets and the acquisition will augment Strides’ footprint in continental Europe with a direct presence in the German speaking markets of Germany, Austria and Switzerland collectively called as DACH region. Strides’ vast international product portfolio and Fairmed Healthcare’s market access in the DACH region is a highly complementary combination to pivot an extensive growth in the coming years. The business will incrementally have access to Strides’ already approved product portfolio for the markets Fairmed operates in with supplies from several of its EU approved facilities.

===Institutional business ===
Strides is an approved supplier to institutionally funded aid projects and Global [[Procurement]] Agencies like [[USAID]], Global Fund, [[PEPFAR]] (The US President's Emergency Plan for [[AIDS]] Relief), [[UNICEF]], [[WHO]], Pan American Health Organization (PAHO), [[United Nations Development Program]] (UNDP), [[Population Services International]] (PSI), Chemeonics, PFSCM, amongst others. Its products are supplied to disease-prone regions in [[Africa]], [[Asia]] and [[Latin America]] with distribution to several areas.

==Manufacturing facilities in India and overseas ==
Strides has a global manufacturing footprint with seven production units spread across three continents. Five of its manufacturing facilities cater to regulated markets have key regulatory approvals including [[USFDA]], [[UK]] MHRA, [[Therapeutic Goods Administration|TGA]], [[Pharmaceuticals and Medical Devices Agency|PMDA]] ANVISA, [[WHO]]. The Company also own two dedicated production facilities for the emerging markets at [[Kenya]] and [[Bengaluru]], [[India]].

==Research and development in Bengaluru, India==
Strides is led and driven by its expertise in [[Research and Development]], visible through its success in creating niche and differentiated products portfolio. Its Global Formulation [[R&D]] centre at [[Bangalore]] drives high value product delivery via latest technology platforms.

==References==
{{reflist}}

== External links ==
* {{official website|http://www.strides.com}}
* https://www.thehindubusinessline.com/companies/strides-shasun-seeks-shareholders-nod-to-change-name-to-strides-pharma-science/article24021359.ece
* https://www.business-standard.com/article/companies/strides-pharma-gets-us-fda-approval-for-hypokalemia-treatment-drug-118090500840_1.html
* http://www.thehindu.com/business/Industry/shasun-pharmaceuticals-to-merge-with-strides-arcolab/article6458529.ece
* http://businesstoday.intoday.in/story/best-indian-ceos-2014-arun-kumar-strides-arcolab-pharma/1/212734.html

[[Category:Pharmaceutical companies of India]]
[[Category:Companies based in Bangalore]]
[[Category:Pharmaceutical companies established in 1990]]
[[Category:1990 establishments in Karnataka]]
[[Category:Indian companies established in 1990]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Companies listed on the Bombay Stock Exchange]]

Strides Pharma Science Limited - Revision history

UpdateBot: robot: Update article (please report if you notice any mistake or error in this edit)

imported>HHHHHYYYY: #suggestededit-add 1.0